Something-mab: Monoclonal Antibodies, Amyloid, and the search for an Alzheimer’s Treatment
The search for an Alzheimer’s disease treatment has been a long and rocky road and with time ticking for many patients, the pressure to provide efficacious treatment is on. To the point where in our opinion, some pharmaceutical companies may be overselling their results.
"Despite promising signs, the search for Alzheimer’s treatment is ongoing and complex" is our latest op-ed published in the Daily Maverick
Written by Morgan Watson, Jessica Henn and John Joska